A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

Key facts

Sponsor

Eli Lilly and Company

Principal Investigator

Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)

Eli Lilly and Company

Intervention

Dulaglutide(drug)

Enrollment

55 enrolled

Eligibility

10-17 years · All sexes

Timeline

2025 – 2027

Study locations (30)

• University of Arizona, Tucson, Arizona, United States
• Arkansas Childrens Hospital, Little Rock, Arkansas, United States
• Division of Endocrinology, Diabetes, and Metabolism, Los Angeles, California, United States
• UCLA Mattel Children's Hospital, Los Angeles, California, United States
• University of California, San Francisco, San Francisco, California, United States
• Children's Hospital of Colorado, Denver, Colorado, United States
• Yale Diabetes Research, New Haven, Connecticut, United States
• Emerson Clinical Research Institute, Washington D.C., District of Columbia, United States
• Children's National Medical Center, Washington D.C., District of Columbia, United States
• Nemours Children's Health, Jacksonville, Florida, United States
• D&H National Research Centers, Inc, Miami, Florida, United States
• AdventHealth Orlando, Orlando, Florida, United States
• D&H Tamarac Research Center, LLC, Tamarac, Florida, United States
• University of South Florida, Tampa, Florida, United States
• Children's Healthcare of Atlanta - Center for Advanced Pediatrics, Atlanta, Georgia, United States
• +15 more locations on ClinicalTrials.gov

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Periodontal Ehlers-Danlos syndrome

Additional recruiting or active studies for the same condition.

• RECRUITINGNANCT07528547
  Hypersight and Ethos In Pediatric Radiotherapy
  University Health Network, Toronto
• RECRUITINGPHASE4NCT06590402
  Anterior Femoral and Adductor Canal Nerve Blocks in Peds Knees
  Hospital for Special Surgery, New York
• RECRUITINGPHASE3NCT05261139
  EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease
  Pfizer
• RECRUITINGPHASE4NCT04040452
  Continuous vs Intermittent Ketorolac for Pain Control in Peds CV Surgery
  Phoenix Children's Hospital

See all trials for Periodontal Ehlers-Danlos syndrome →